Gene · 657
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hereditary Hemorrhagic Telangiectasia in a Young Adult: Gastrointestinal Arteriovenous Malformations as a Presenting Feature. | Cureus | 2023 | 37746506 | PubTator, text mining | PubMed |
| Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome. | Front Oncol | 2023 | 37746257 | PubTator, text mining | PubMed |
| Elevated BMPR2 expression amplifies osteoblast differentiation in ankylosing spondylitis. | J Rheum Dis | 2023 | 37736586 | PubTator, text mining | PubMed |
| Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology. | J Cancer Res Clin Oncol | 2023 | 37733241 | PubTator, text mining | PubMed |
| Characterization of Fibrodysplasia Ossificans Progessiva relevant Acvr1/Acvr2 Activin receptors in medaka (Oryzias latipes). | PLoS One | 2023 | 37708126 | PubTator, text mining | PubMed |
| A Novel RUNX1 Genetic Variant Identified in a Young Male with Severe Osteoporosis. | JBMR Plus | 2023 | 37701147 | PubTator, text mining | PubMed |
| Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients. | Cancer Med | 2023 | 37694493 | PubTator, text mining | PubMed |
| Characterization of erythroferrone oligomerization and its impact on BMP antagonism. | bioRxiv | 2023 | 37693455 | PubTator, text mining | PubMed |
| SHH medulloblastoma and very early onset of bowel polyps in a child with PTEN hamartoma tumor syndrome. | Front Mol Neurosci | 2023 | 37692099 | PubTator, text mining | PubMed |
| Matriptase-2 regulates iron homeostasis primarily by setting the basal levels of hepatic hepcidin expression through a nonproteolytic mechanism. | J Biol Chem | 2023 | 37690687 | PubTator, text mining | PubMed |
| Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2023 | 37686604 | PubTator, text mining | PubMed |
| CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2023 | 37686014 | PubTator, text mining | PubMed |
Report on the Effect of the Implementation of an Early Detection and Prevention of Cancer Program on Families at High Hereditary Risk-Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland. | Int J Mol Sci | 2023 | 37685988 | PubTator, text mining | PubMed |
| A Novel Mutation of MSH2 Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies. | J Clin Med | 2023 | 37685569 | PubTator, text mining | PubMed |
| Human iPSCs as Model Systems for BMP-Related Rare Diseases. | Cells | 2023 | 37681932 | PubTator, text mining | PubMed |
| Taste papilla cell differentiation requires the regulation of secretory protein production by ALK3-BMP signaling in the tongue mesenchyme. | Development | 2023 | 37680190 | PubTator, text mining | PubMed |
| Mobilisation of jerboa kidney gene networks during dehydration and opportunistic rehydration. | iScience | 2023 | 37664605 | PubTator, text mining | PubMed |
| METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway. | Biol Direct | 2023 | 37658413 | PubTator, text mining | PubMed |
| Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel. | PLoS One | 2023 | 37656691 | PubTator, text mining | PubMed |
| Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes. | Stem Cell Res Ther | 2023 | 37649113 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/657/papers?page=10